Annual EBITDA
-$7.63 M
-$2.02 M-36.02%
December 1, 2023
Summary
- As of February 22, 2025, BIAF annual EBITDA is -$7.63 million, with the most recent change of -$2.02 million (-36.02%) on December 1, 2023.
- During the last 3 years, BIAF annual EBITDA has fallen by -$767.70 thousand (-11.19%).
- BIAF annual EBITDA is now -43.47% below its all-time high of -$5.32 million, reached on December 31, 2021.
Performance
BIAF EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.83 M
+$106.10 K+5.49%
September 1, 2024
Summary
- As of February 22, 2025, BIAF quarterly EBITDA is -$1.83 million, with the most recent change of +$106.10 thousand (+5.49%) on September 1, 2024.
- Over the past year, BIAF quarterly EBITDA has dropped by -$40.40 thousand (-2.26%).
- BIAF quarterly EBITDA is now -214.19% below its all-time high of $1.60 million, reached on June 30, 2021.
Performance
BIAF Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$7.74 M
+$396.80 K+4.88%
September 1, 2024
Summary
- As of February 22, 2025, BIAF TTM EBITDA is -$7.74 million, with the most recent change of +$396.80 thousand (+4.88%) on September 1, 2024.
- Over the past year, BIAF TTM EBITDA has increased by +$178.00 thousand (+2.25%).
- BIAF TTM EBITDA is now -875.73% below its all-time high of $997.60 thousand, reached on June 30, 2021.
Performance
BIAF TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BIAF EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.0% | -2.3% | +2.3% |
| 3 y3 years | -11.2% | -2.3% | +2.3% |
| 5 y5 years | -11.2% | -2.3% | +2.3% |
BIAF EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.5% | at low | -684.5% | +63.0% | -45.5% | +17.4% |
| 5 y | 5-year | -43.5% | at low | -214.2% | +63.0% | -875.7% | +17.4% |
| alltime | all time | -43.5% | at low | -214.2% | +63.0% | -875.7% | +17.4% |
BioAffinity Technologies EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.83 M(-5.5%) | -$7.74 M(-4.9%) |
| Jun 2024 | - | -$1.93 M(+8.2%) | -$8.14 M(+2.8%) |
| Mar 2024 | - | -$1.78 M(-18.7%) | -$7.92 M(+3.8%) |
| Dec 2023 | -$7.63 M(+36.0%) | -$2.20 M(-1.1%) | -$7.63 M(+8.8%) |
| Sep 2023 | - | -$2.22 M(+29.7%) | -$7.01 M(-20.4%) |
| Jun 2023 | - | -$1.71 M(+14.4%) | -$8.81 M(+29.8%) |
| Mar 2023 | - | -$1.50 M(-5.1%) | -$6.79 M(+12.8%) |
| Dec 2022 | -$5.61 M | -$1.58 M(-60.8%) | -$6.01 M(-35.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$4.02 M(-1387.8%) | -$9.37 M(+39.3%) |
| Jun 2022 | - | $312.30 K(-143.0%) | -$6.73 M(+23.6%) |
| Mar 2022 | - | -$726.00 K(-85.3%) | -$5.44 M(+2.4%) |
| Dec 2021 | -$5.32 M(-22.5%) | - | - |
| Dec 2021 | - | -$4.94 M(+258.6%) | -$5.32 M(+1300.9%) |
| Sep 2021 | - | -$1.38 M(-186.2%) | -$379.60 K(-138.1%) |
| Jun 2021 | - | $1.60 M(-366.0%) | $997.60 K(-266.0%) |
| Mar 2021 | - | -$601.00 K | -$601.00 K |
| Dec 2020 | -$6.86 M | - | - |
FAQ
- What is bioAffinity Technologies annual EBITDA?
- What is the all time high annual EBITDA for bioAffinity Technologies?
- What is bioAffinity Technologies annual EBITDA year-on-year change?
- What is bioAffinity Technologies quarterly EBITDA?
- What is the all time high quarterly EBITDA for bioAffinity Technologies?
- What is bioAffinity Technologies quarterly EBITDA year-on-year change?
- What is bioAffinity Technologies TTM EBITDA?
- What is the all time high TTM EBITDA for bioAffinity Technologies?
- What is bioAffinity Technologies TTM EBITDA year-on-year change?
What is bioAffinity Technologies annual EBITDA?
The current annual EBITDA of BIAF is -$7.63 M
What is the all time high annual EBITDA for bioAffinity Technologies?
bioAffinity Technologies all-time high annual EBITDA is -$5.32 M
What is bioAffinity Technologies annual EBITDA year-on-year change?
Over the past year, BIAF annual EBITDA has changed by -$2.02 M (-36.02%)
What is bioAffinity Technologies quarterly EBITDA?
The current quarterly EBITDA of BIAF is -$1.83 M
What is the all time high quarterly EBITDA for bioAffinity Technologies?
bioAffinity Technologies all-time high quarterly EBITDA is $1.60 M
What is bioAffinity Technologies quarterly EBITDA year-on-year change?
Over the past year, BIAF quarterly EBITDA has changed by -$40.40 K (-2.26%)
What is bioAffinity Technologies TTM EBITDA?
The current TTM EBITDA of BIAF is -$7.74 M
What is the all time high TTM EBITDA for bioAffinity Technologies?
bioAffinity Technologies all-time high TTM EBITDA is $997.60 K
What is bioAffinity Technologies TTM EBITDA year-on-year change?
Over the past year, BIAF TTM EBITDA has changed by +$178.00 K (+2.25%)